211 related articles for article (PubMed ID: 34012635)
1. Identification of gene signatures and potential therapeutic targets for acquired chemotherapy resistance in gastric cancer patients.
Sun J; Zhao J; Yang Z; Zhou Z; Lu P
J Gastrointest Oncol; 2021 Apr; 12(2):407-422. PubMed ID: 34012635
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
Qin X; Song Y
Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
[TBL] [Abstract][Full Text] [Related]
3. Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
Wang W; Wang S; Pan L
Exp Ther Med; 2020 Oct; 20(4):3720-3732. PubMed ID: 32855723
[TBL] [Abstract][Full Text] [Related]
4. Identification of key miRNAs and their targets in peripheral blood mononuclear cells of IgA nephropathy using bioinformatics analysis.
Liu L; Yang Y; Yu D
Medicine (Baltimore); 2021 Jul; 100(26):e26495. PubMed ID: 34190177
[TBL] [Abstract][Full Text] [Related]
5. Identification of biomarkers and construction of a microRNA-mRNA regulatory network for ependymoma using integrated bioinformatics analysis.
Yang B; Dai JX; Pan YB; Ma YB; Chu SH
Oncol Lett; 2019 Dec; 18(6):6079-6089. PubMed ID: 31788082
[TBL] [Abstract][Full Text] [Related]
6. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T; Gao X; Han L; Yu J; Li H
World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
[TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
8. Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data.
Zhang L; Chen J; Cheng T; Yang H; Pan C; Li H
Biomed Res Int; 2020; 2020():1980921. PubMed ID: 32714975
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
Xue B; Li S; Jin X; Liu L
BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
[TBL] [Abstract][Full Text] [Related]
10. Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.
Heidarzadehpilehrood R; Pirhoushiaran M; Binti Osman M; Ling KH; Abdul Hamid H
Iran J Pharm Res; 2023; 22(1):e139985. PubMed ID: 38444712
[TBL] [Abstract][Full Text] [Related]
11. Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA-mRNA Network in Neuroblastoma Via Bioinformatics Analysis.
Chen B; Hua Z; Qin X; Li Z
Neurochem Res; 2021 Feb; 46(2):197-212. PubMed ID: 33104965
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis of mRNAs and miRNAs for Identifying Potential Biomarkers in Lung Adenosquamous Carcinoma.
Nie J; Gong L; Li Z; Ou D; Zhang L; Liu Y; Zhang J; Liu D
Comput Math Methods Med; 2022; 2022():5851269. PubMed ID: 35281953
[TBL] [Abstract][Full Text] [Related]
13. Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis.
Zhong X; Huang G; Ma Q; Liao H; Liu C; Pu W; Xu L; Cai Y; Guo X
Medicine (Baltimore); 2019 Jul; 98(27):e16269. PubMed ID: 31277149
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of the microRNAs and hub genes for pancreatic ductal adenocarcinoma by an integrated bioinformatic analysis.
Xin W; Fu Y; Chen L; Ding H; Feng T; Sun J; Qi Y; Hu Y; Fang Q; Fang L
J Gastrointest Oncol; 2023 Apr; 14(2):719-732. PubMed ID: 37201049
[TBL] [Abstract][Full Text] [Related]
15. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
16. Identifying hub genes and miRNAs in Crohn's disease by bioinformatics analysis.
Sun Y; Cai D; Hu W; Fang T
Front Genet; 2022; 13():950136. PubMed ID: 36118873
[No Abstract] [Full Text] [Related]
17. Identification of Tissue-Specific Expressed Hub Genes and Potential Drugs in Rheumatoid Arthritis Using Bioinformatics Analysis.
Xing X; Xia Q; Gong B; Shen Z; Zhang Y
Front Genet; 2022; 13():855557. PubMed ID: 35368701
[No Abstract] [Full Text] [Related]
18. Identification of differentially expressed mRNAs as novel predictive biomarkers for gastric cancer diagnosis and prognosis.
Zhou JW; Zhang YB; Huang ZY; Yuan YP; Jin J
World J Gastrointest Oncol; 2024 May; 16(5):1947-1964. PubMed ID: 38764850
[TBL] [Abstract][Full Text] [Related]
19. Identification of Novel Kinase-Transcription Factor-mRNA-miRNA Regulatory Network in Nasopharyngeal Carcinoma by Bioinformatics Analysis.
Gao L; Zhou L; Huang X
Int J Gen Med; 2021; 14():7453-7469. PubMed ID: 34744455
[TBL] [Abstract][Full Text] [Related]
20. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
